Master of Pharmacy (Pharmaceutics)
|
|
- Roxanne Hampton
- 6 years ago
- Views:
Transcription
1 Study & Evaluation Scheme of Master of Pharmacy (Pharmaceutics) [Applicable w.e.f. Academic Session till revised] TEERTHANKER MAHAVEER UNIVERSITY N.H.-24, Delhi Road, Moradabad, Uttar Pradesh Website: ( ) Page 1 of 16
2 TEERTHANKER MAHAVEER UNIVERSITY (Established under Govt. of U. P. Act No. 30, 2008) Delhi Road, Bagarpur, Moradabad (U.P) Study & Evaluation Scheme of MASTER OF PHARMACY SUMMARY Programme : M. Pharm. (Pharmaceutics) Duration : Two years full time Medium : English Minimum Required Attendance : 75 % Credit Maximum Credits Minimum credits required for degree : 95 : 90 Assessment Internal External Total : Internal Evaluation (Theory Papers) : Clas s Test I Clas s Test II Clas s Test III Continuou s Evaluatio n Semin ar Total Theory Practical Duration of Examination : External Internal External Internal 3 hrs. 1.5 hrs. 4 hrs. 4 hrs. To qualify the course a student is required to secure a minimum of 40% marks in aggregate in the end semester examination and teachers continuous evaluation (i.e. both internal and external). A candidate who secures less than 40% of marks in a course shall be deemed to have failed in that course. The student should have overall 50% marks in a semester to clear the semester. In case a student has more than 40% in each course but less than 50% overall in a semester he/she shall re-appear in one or two course(s) to improve the percentage. There will be three Class Tests in a semester and an average of the marks obtained in best two tests will be computed (cumulatively) for the final result. The class tests would comprise of five questions. Student shall have to answer three questions out of which one question will be compulsory. Each question would be of five marks. Question Paper Structure: 1. The question paper shall consist of eight questions. Out of which first question shall be of short answer type (not exceeding 50 words) and will be compulsory. Question No. 1 shall contain 8 parts representing all units of the syllabus and students shall have to answer any five (weightage 4 marks each). 2. Out of the remaining seven questions, a student shall be required to attempt any five questions. There will be minimum one and maximum two questions from each unit of the syllabus. The weightage of Question No. 2 to 8 shall be 10 marks each. ( ) Page 2 of 16
3 Study & Evaluation Scheme Programme: M. Pharm. Semester I Course Subject Periods Evaluation Scheme S.N. Code L T P C Internal External Total 1 MPA101 Modern Analytical Techniques MPU101 Pharmaceutical Biostatics and Computer Application 3 MPU102 Product Development MPA151 Modern Analytical Techniques (MAT) Lab 5 MPU152 Product Development Lab Total Semester II Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU201 Pharmaceutical Production Management 2 MPU202 Recent Advances in Drug Delivery System 3 MPU203 Bio-pharmaceutics & Pharmacokinetics 4 MPU251 Research Project Synopsis MPU252 Recent Advances in Drug Delivery System Lab 6 MPU253 Bio-pharmaceutics & Pharmacokinetics Lab Total Semester III Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU351 Research Project Phase -I Total Semester IV Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU451 Research Project Phase -II (Thesis compilation and Viva-Voce) Total Research Project shall be carried out in different stages. It will commence with submission and approval of synopsis in second semester. The experimental work shall be carried out in two phases i.e. in III & IV semesters. Note: L Lecture T- Tutorial P- Practical C- Credits 1L = 1Hr 1T= 1 Hr 1P=1 Hr 1C =1Hr of Theory paper = 2Hrs of Practical ( ) Page 3 of 16
4 M. Pharm. Semester I MODERN ANALYTICAL TECHNIQUE Course Code: MPA101 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with Principle, theory & instrumentation of sophisticated pharmaceutical analysis instruments and the interpretation of their spectra. Unit - 1 Principle, theory & instrumentation of UV-Visible spectroscopy, it s utility in structural qualitative and quantitative analysis of drug molecules, Woodward Fischer rules and use of Shiff s reagents for elucidation of structure. Unit 2 Infrared spectroscopy, I.R radiation and its interaction with organic molecules, vibrational mode of bonds, instrumentation and application, effect of hydrogen bonding and conjugation on absorption bands, interpretation of IR Spectra, FTIR and ATR. Unit 3 Nuclear magnetic resonance spectroscopy: chemical shift concept, isotopic nuclei, reference standards and solvents. 1 H NMR spectra, coupling constants, interpretation of spectra, decouplingdouble resonance and shift reagent methods. Principles of FT-NMR with reference to 13 C NMR, free induction decay. Spin-spin and spin-lattice relaxation phenomenon. Nuclear overhauser enhanced 13 C NMR spectra, their interpretation and application. Unit 4 Mass spectrometry: Basic principles and brief outline of instrumentation. Ion formation, molecular ion, metastable ion, fragmentation process in relation to molecular structure and functional groups. Relative abundance of isotopes, chemical ionization, GC-MS and LC/MS. Interpretation of spectra of simple molecules. Unit 5 Chromatographic techniques: Principles of separation and application of Column, Paper, Thin layer and Gas chromatography, HPLC, HPTLC, Electrophoresis. Instrumentation of HPLC, Reverse phase columns. Pharmaceutical evaluation of drug in biological fluids- bioassays. Radioimmunoassay. Recommended Books 1. Willard, H.H., Merrit, L.L., Dean, J.A., Settle, P.A., Instrumental Methods of Analysis, Van Nostrand. 2. Skoog, D.A., Heller, F.J., Nieman, T.A., Principles of Instrumental Analysis, WB Saunders. 3. Haswell, S.J., ed. Atomic Absorption Spectroscopy, Elsevier. 4. Ardrey, R.E., Pharmaceutical Mass Spectra, Pharmaceutical Press, London. 5. Sethi, P.D., Quantitative Analysis of Pharmaceutical Formulations, CBS Publishers, New Delhi. 6. Kalsi, P.S., Spectroscopy of Organic Compounds, New Age Publishers, New Delhi. 7. Gross J.H., Mass Spectrometry, Springer Berlin, Heidelberg. 8. Haffmann D. H., Advances in Chromatography, Marcel Dekker. 9. Robert D. Braun, Introduction to Instrumental Analysis, McGraw-Hill. 10. Wilfried, M.A. Niessen- Liquid Chromatography-Mass Spectrometry, Marcel Dekker. *Latest editions of all the suggested books are recommended. ( ) Page 4 of 16
5 Semester I PHARMACEUTICAL BIOSTATICS AND COMPUTER APPLICATIONS Course Code: MPU101 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with pharmaceutical biostatics and computer applications. Unit - 1 Methods of collection of data, classifications and graphical representation of data. Binomial and normal probability distribution. Polygon, histogram, measure of central tendency. Significance of statistical methods, probability, degree of freedom, measures of variation - Standard deviation, Standard error. Unit - 2 Sampling, sample size and power. Statistical inference and hypothesis. Tests for statistical significance: student t-test, Chi-square test, confidence level, Null hypothesis. Unit - 3 Linear regression and correlation. Analysis of Variance (one way and two way). Factorial designs (including fraction factorial design). Theory of probability, Permutation and Combination, Ratios, Percentage and Proportion. Two way ANOVA and Multiple comparison procedures. Unit - 4 Non-parametric tests, Experimental design in clinical trials, Statistical quality control, Validation, Optimization techniques and Screening design. Correlation and regression, least square method, significance of coefficient of correlation, nonlinear regression. Unit - 5 Bioassays-calculations of doses response relationships, LD 50, ED 50. Applications of software for statistical calculation viz. SPSS, foxtron. Recommended Books 1. Bolton, Pharmaceuticals Statistics- Practical & Clinical Applications, Marcel & Dekker, New York. 2. Fisher, R.A., Statistical Methods for Research Works, Oliver & Boyd, Edinburgh. 3. Chow, Statistical Design and Analysis of Stability Studies, Marcel Dekker, New York. 4. Buncher, Statistics in the Pharmaceutical Industry, Marcel Dekker, New York. 5. Finney, D.J., Statistical Methods in Biological Assays, Hafner, New York. 6. Montgomery, D.C., Introduction to Statistical Quality Control, Willy. 7. Lipschutz, Introduction to Probability and Statistics, McGraw-Hill. 8. Li wan Po, Statistics for Pharmacist, Wiley-Blackwell. * Latest editions of all the suggested books are recommended. ( ) Page 5 of 16
6 Semester I PRODUCT DEVELOPMENT Course Code: MPU102 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with product development. Unit-1 PREFORMULATION STUDIES Timings and goals of Preformulation. pre-formulation methodology, solid stat properties, partition coefficient, solubility, dissolution, crystal from the stability, compatibility tests, dissolution of drug substances and dosage forms, Pediatric & geriatric aspects of formulation. Unit -2 PHARMACEUTICAL PROCESS VALIDATION Regulatory basis, validation of sterile products, solid dosage forms, process. Drug additive interaction. Unit-3 STABILITY Theoretical considerations, Degradative pathways, Stability indicating assays, Influence of packaging components on dosage form stability, Stabilization of Pharmaceutical formulations (solid, liquid and semi solid formulations). Unit-4 Evaluation of Pharmaceutical formulations in vitro and in vivo studies and their correlation. Levels and types of IV-IVC. Unit -5 POLYMERS Types, Pharmaceutical Application, Molecular Weight Determination, Conformation of dissolved linear macromolecules, Polymer solutions, Polymer in solid state, Fabrication. PACKAGING DEVELOPMENT- Packaging materials, Types, Labeling, Preformulation screening of packaging components. Recommended Books 1. Bannker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 2. Liberman H.A. et al, Pharmaceutical Dosage Forms-Tablets, Marcel Dekker, New York. 3. Lachman L, Lieberman H.A. & Kanig J.L. The Theory & Practice of Industrial Pharmacy. Varghese Publishing Home. 4. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone. 5. Liberman H.A. et al, Pharmaceutical Dosage Forms-Parenterals, Marcel Dekker, New York. 6. Carstensen J.T., Drug Stability-Principles & Practice, Marcel Dekker, New York. 7. Malmsten M., Surfactants and Polymers in Drug Delivery, Marcel Dekker, New York. 8. Ansel H.A. - Pharmaceutical Dosage Forms, Lippincott Williams & Wilkins. 9. Sarfaraz K. Niazi, Handbook of Preformulations: Chemical, Biological and Botanical Drugs, CRC Press. *Latest editions of all the suggested books are recommended ( ) Page 6 of 16
7 Semester I MODERN ANALYTICAL TECHNIQUE (MAT) LAB Course Code: MPA151 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with different analytical instruments. Based on the Course Code: MPA101 ( ) Page 7 of 16
8 Semester I PRODUCT DEVELOPMENT LAB Course Code: MPU152 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with product development practicals. Based on Course Code MPU103 ( ) Page 8 of 16
9 Semester II PHARMACEUTICAL PRODUCTION MANAGEMENT Course Code: MPU201 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with pharmaceutical production management. Unit-1 Status of Pharmaceutical industry with special reference to post GATT scenario. Project planning and implementation. Transfer of Technology. Unit-2 Master formula generation and SOP. Pilot plant scale up techniques. Unit-3 Factory layout, Material Management: Unit-4 Process optimization and automation in pharmaceutical manufacturing. Unit-5 Inventory control. Different Systems of inventory control. Import and Export regulations laws and methods to obtain I & E licenses, I and E regulations USA, EU and Japanese perspectives. Recommended Books 1. Banker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 2. Remington, The Science & Practice of Pharmacy, Lippincott. William & Wilkins. 3. Lachman L, Lieberman H.A. & Kanig J.L., The Theory & Practice of Industrial Pharmacy, Varghese Publishing Home. 4. Aulton M.E., Pharmaceutics The Science of Dosage form Design, Churcill Livingstone. 5. Levin M.A., Pharmaceutical Process Scale up, Marcel Dekker, New York. 6. Dutta A.K., Material Management, Prentice Hall India. 7. Chary S.N., Production and Operative Management, Tata-Mcgraw Hill, India. 8. Kennedy T., Pharmaceutical Project Management, Marcel Dekker, New York. * Latest editions of all the suggested books are recommended ( ) Page 9 of 16
10 Semester II RECENT ADVANCES IN DRUG DELIVERY SYSTEM Course Code: MPU202 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with novel techniques and advances in drug delivery system. Unit-1 Formulation considerations with special emphasis on release patterns. Sustained and Controlled release- oral, dental, nasal, ocular & parenteral systems. Unit-2 Fast Release- Introduction, formulation & evaluation. Unit-3 Transdermal Drugs Delivery System- Factors influencing transdermal delivery, formulation & evaluation including Iontophoresis and Ionophoresis. Unit-4 Target Oriented Drug Delivery Systems- prodrugs, Liposome, Niosome, nanoparticles Microspheres and microparticles. Lipoproteins Activated Carbons, Cellular Carriers, Antibodies, DNA, And Low Molecular Weight Proteins. Hormones, Dextran & Polysaccharides, Synthetic Polymers, Nanoparticles, Microparticles fabrication techniques (Latest Advances). Unit-5 Nutraceuticals- introduction & scope. Recommended Books 1. Chien Y.W., Novel Drug Delivery Systems-Fundamentals, Developmental Concepts. Biomedical Assessment, Marcel Dekker, New York. 2. Chien Y.W., ed., Transdermal Controlled Systemic Medications, Marcel Dekker, New York. 3. Schreyer, H., Drug Targeting Technology Physical, Chemical & Biological Methods, Marcel Dekker, New York. 4. Banker G.S. & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 5. Gennaro A.R., Remington, The Science & Practice of Pharmacy, Lippincott. Williams & Wilkins. 6. Lachman L., Lieberman B.A & Kanig I.L., The Theory & Practice of Industrial Pharmacy, Varghese Publishing Home. 7. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone. 8. Potts R.O. & Guy R.H., Mechanism of Trans dermal Drug Delivery, Marcel Dekker, New York. * Latest editions of all the suggested books are recommended. ( ) Page 10 of 16
11 Semester II BIO-PHARMACEUTICS & PHARMACOKINETICS Course Code: MPU203 L- 4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with bio-pharmaceutics & pharmacokinetics. Unit-1 Drug Absorption Distribution & Disposition. Unit-2 Pharmacokinetics. Open one compartment, two compartment & three compartment models & their limitations. Non-compartmental pharmacokinetics. Graphical methods of calculating pharmacokinetic parameters. Unit-3 Factors influencing bio-availability, evaluation of bioavailability, bio-equivalence with reference to BCS. Unit-4 Dosage Regimens, Repetitive dosing and dose adjustments in renal and hepatic failure, individualization of dosage regimen. Unit-5 Pharmacokinetic applications in Clinical practice. Principles of clinical trial. Recommended Books 1. Notari, R.E., Biopharmaceutics and Pharmacokinetics An introduction, Marcel Dekker Inc. N.Y. 2. Rowland M., and Tozer T.N., Clinical Pharmacokinetics, Lea and Febriger, N.Y. 3. Wagner J.G., Fundamentals of Clinical Pharmacokinetics, Drugs Intelligence Publishers, Hamilton. 4. Wagner J.G., Pharmacokinetics for the Pharmaceutical Scientist, Technomic Publishing A.G. Basel, Switzerland. ( ) Page 11 of 16
12 Semester II RESEARCH PROJECT SYNOPSIS Course Code: MPU251 L-0, T-2, P-0, C-1 Objective: The basic objective of this course is to get familiar with the method, instrumentation and the technology of the topic that is selected for the dissertation. Guidelines: 1. The course will comprise of preparation of synopsis for the proposed research work to be done during third and fourth semester courses. 2. The allotted supervisor will provide guidelines and determine the topic of the research work based on thorough literature reviews. 3. The final presentation will be evaluated by the supervisor(s) concerned for 25 marks. 4. A committee of senior faculty of the institute including supervisor(s), will finally evaluates the quality of the proposed work and its relevance in the pharmaceutical field (out of 75 marks). ( ) Page 12 of 16
13 Semester II RECENT ADVANCES IN DRUG DELIVERY SYSTEM LAB Course Code MPU252 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with practicals related novel techniques and advances in drug delivery system. Based on the Course Code: MPU202 ( ) Page 13 of 16
14 Semester II BIO-PHARMACEUTICS & PHARMACOKINETICS LAB Course Code: MPU253 L- 0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with pharmacokinetic practicals. Based on the Course Code: MPU203 ( ) Page 14 of 16
15 Semester III RESEARCH PROJECT (PHASE-I) (TO BE CONTINUED IN SEMESTER-IV) Course Code: MPU351 L- 0, T-0, P-48, C-24 Objective: The basic objective of this course is to represent the findings of the project that has been done in the dissertation. Guidelines: 1. The course will comprise of the confirmation of the proposed research work based on the initial experimentation to confirm the feasibility of the work. 2. The allotted supervisor(s) will provide guidelines with exploration of the line of action with recent trends of research in the related field and confirm global acceptability with regards to industry and academic problems. 3. The continuous literature survey and modification of experimental pathway will be taken in to practice with regular monitoring. 4. The candidate s performance will be evaluated by the supervisor(s) and the internal committee of at least three senior faculties in addition to the allotted supervisor(s). There will be atleast two seminars to be presented before the committee in this semester consisting of the progress of the research work. 5. Each seminar will be of 50 marks. ( ) Page 15 of 16
16 Semester IV RESEARCH PROJECT (PHASE II) (THESIS COMPILATION & VIVA-VOCE) Course Code: MPU451 L-0, T-0, P-48, C-24 Objective: The basic objective of this course is to present the findings of the project that has been carried out in different phases. Guidelines: 1. The progress of research work will be continuously evaluated by the supervisor(s) concerned. 2. There will be at least two presentations in this semester and each will be evaluated out of 25 marks by the internal committee of at least three senior faculties beside the allotted supervisor(s). 3. The external examiner appointed by the university will finally evaluate the thesis by way of viva- voce and presentation by the candidate out of the remaining 50 marks. ( ) Page 16 of 16
Master of Pharmacy (Pharmacology) [Applicable w.e.f. Academic Session till revised]
Study & Evaluation Scheme of Master of Pharmacy (Pharmacology) [Applicable w.e.f. Academic Session 2011-12 till revised] TEERTHANKER MAHAVEER UNIVERSITY N.H.-24, Delhi Road, Moradabad, Uttar Pradesh-244001
More informationInternational Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW
International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW SUKHDEV SINGH *1 AND JASBIR SINGH 2 1 Rayat Institute
More informationPHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM
Course Title Course Code PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM QA204 Lecture : 04 Course Credit Practical : 04 Tutorial : 00 Total : 08 Course Objective To explain the students about
More informationWHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability
2017 WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability Eric C Buxton Clinical Associate Professor University of Wisconsin Madison School of Pharmacy, Division of Pharmacy
More informationGraduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description:
The following is a listing of courses offered by the Graduate Program in Pharmaceutical Science. Prerequisites and brief descriptions are included for each course. For more information on a particular
More informationBIOPHARMACEUTICS AND PHARMACOKINETICS
BIOPHARMACEUTICS AND PHARMACOKINETICS (JULIO 2015) Degree in PHARMACY University of Alcalá Academic year 2015/16 3 rd Year 1 st Season COURSE DESCRIPTION Title: Biopharmaceutics and Pharmacokinetics Code:
More informationBIOPHARMACEUTICS AND PHARMACOKINETICS. University of Alcalá. Academic year 2016/17 3 rd Year 1 st Season
BIOPHARMACEUTICS AND PHARMACOKINETICS Degree in PHARMACY University of Alcalá Academic year 2016/17 3 rd Year 1 st Season COURSE DESCRIPTION Title: Biopharmaceutics and Pharmacokinetics Code: 570014 Degree:
More informationAnalytical Methods Development and Validation
Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the
More informationDesign and Dosage Form. Dr. Deny Susanti
Design and Dosage Form Dr. Deny Susanti Example 1 Aspirin tablet is stable but not as a liquid dosage form How to design liquid form? Soluble or dispersible aspirin tablets-to be dissolved in water Note:
More informationThe course is taught by a team of UNC faculty and industry scientists. The course has been designed to provide the students an understanding of
Drug Metabolism MOPH 810 Fall 2009 Classes: 80 minute class twice a week Course Director: Dhiren R. Thakker Eshelman School of Pharmacy, UNC-Chapel Hill The course is taught by a team of UNC faculty and
More informationSince 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm
Since 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm Hons.) program and one year Master of Science in Pharmaceutical Technology (MS. Pharm Tech) program. The Pharmacy department
More informationGuide. recombinant DNA proteins. for the elaboration of monographs on synthetic peptides and. European Pharmacopoeia
Guide for the elaboration of monographs on synthetic peptides and recombinant DNA proteins European Pharmacopoeia European Directorate for the Quality of Medicines & HealthCare Edition Council of Europe,
More informationGUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)
GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) DRAFT GUIDANCE This guidance document is for feedback purposes only Comments and suggestions regarding this draft document should be submitted within
More informationSetting Specifications
536 LCGC NORTH AMERICA VOLUME 22 NUMBER 6 JUNE 2004 www.chromatographyonline.com Setting Specifications Validation Viewpoint Specifications establish the criteria to which a drug substance or product should
More informationMaster List of Professional Electives Course Title Description Credit Hours. Note: This class only meets for the last 7 class periods of the semester.
Course Number PHTH7044 PHRX7064 PHRX704C PHRX706 PHTH8048 PHRX 904 PHRX 904 Master List of Professional Electives Course Title Description Credit Hours Advanced Cardiac Life Support Emphasis (P only) Advanced
More informationAbstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2
Abstract GastroPlus is a mechanistically based simulation software package that predicts absorption, pharmacokinetics, and pharmacodynamics in humans and animals. GastroPlus modeling and simulation has
More informationApplication of Quality by Design (QbD) in product development. James E. Polli September 16, 2015
Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route
More informationPharmaceutical Sciences
SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning
More informationOfficial Letter from the DOH
Issued Date 2009/04/02 Issued by DOH Ref. No 0980316268 RE The DOH issued an official letter to announce the implementation of the Guideline for BA/BE Studies on April 2, 2009 (Ref. No. 0980316265). Please
More informationPharmaceutical Sciences/Medicinal Chemistry, M.S.
Pharmaceutical Sciences/Medicinal Chemistry, M.S. 1 Pharmaceutical Sciences/Medicinal Chemistry, M.S. SCHOOL OF PHARMACY (http://www.temple.edu/pharmacy) About the Program The School of Pharmacy offers
More informationA.N.U. M.PHARMACY SYLLABUS (WITH EFFECT FROM ACADEMIC YEAR) ACHARYA NAGARJUNA UNIVERSITY MASTER OF PHARMACY
ACHARYA NAGARJUNA UNIVERSITY MASTER OF PHARMACY REGULATIONS AND SYLLABUS Four Semester Pattern (with effect from 2007-2008) 1.1 The Degree of Master of Pharmacy of the Nagarjuna University will be conferred
More informationOverview Stability testing is an essential part of drug development which ensures the quality, safety and efficacy of the drug for the lifetime of the drug product. Appropriate storage conditions can only
More informationPROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Vijayasree et al. SJIF Impact Factor 6.647 Volume 6, Issue 3, 367-874 Review Article ISSN 2278 4357 PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL
More informationSRI SATYA SAI UNIVERSITY OF TECHNOLOGY & MEDICAL SCIENCES
MPCS-101 MODERN ANALYTICAL TECHNIQUES (THEORY) 1. Spectroscopy: a. UV-Visible spectroscopy: Introduction, Theory, Laws, Instrumentation associated with UV-Visible spectroscopy, Choice of solvents and solvent
More informationConjugated protein biotherapeutics
B i o P r o c e s s TECHNICAL Mass Spectrometric Conjugate Characterization Process Qualification of Recombinant Protein Hapten Conjugation Miao-Fang Lin, Margo Wilson, Michael V. Murray, and Greg W. Adams
More informationNOVEL DRUG DELIVERY SYSTEMS II
NOVEL DRUG DELIVERY SYSTEMS II Polymer Science 1. Define Polymer. Describe its properties. 2. Classify polymers based on various criteria. 3. What are the ideal characteristics of biodegradable polymers?
More informationName of Chapter & Details. Section-I
Course Title Course Code APPLIED PHARMACEUTICAL ANALYSIS QA202 Lecture : 04 Course Credit Practical : 04 Tutorial : 00 Total : 08 Course Objectives To explain the students about application of various
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C
More informationSTABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
More informationModel-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017
Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017 Biopharmaceutical Classification System Approximately 80% of drugs in the pharmaceutical compounds
More informationEvaluating single-use systems
B i o p r o c e s s Validation Extractables and Leachables from Single-Use Disposables Denise Bestwick and Raymond Colton Evaluating single-use systems for extractables and leachables is new territory
More informationThe Five Key Elements of a Successful Metabolomics Study
The Five Key Elements of a Successful Metabolomics Study Metabolomics: Completing the Biological Picture Metabolomics is offering new insights into systems biology, empowering biomarker discovery, and
More informationRegulatory Assessment
Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal
More informationGuidance for Industry
Guidance for Industry ANDAs: Impurities in Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should
More informationDrug Development and Incrementally Modified Drugs : Regulatory Perspective. American Association of Pharmaceutical Scientists October 27, 2015
Drug Development and Incrementally Modified Drugs : Regulatory Perspective American Association of Pharmaceutical Scientists October 27, 2015 Larissa Lapteva, M.D., M.H.S., Division of Therapeutic Performance
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF FUDOSTEINE FILM COATED IMMEDIATE RELEASE TABLETS M. CHANDRAKANTH, P. PREM KUMAR, MANOHAR BABU S Department
More informationEnsuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education
Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International
More informationStability of Biological Products
Stability of Biological Products Dr Jurgen Lindner Principal, BioPharma Consulting & Executive Secretary, APIMAA Biological Products Functional Proteins or Polypeptides (mab s, enzymes & inhibitors, growth
More informationFormulation and Evaluation of Gastro retentive Bilayer Tablets- Glimepiride as Sustained Release and Lisinopril as Immediate Release
Farhat A et al / Int. J. of Pharmacy and Analytical Research Vol-5(4) 216 [658-669] IJPAR Vol.5 Issue 4 Oct - Dec -216 Journal Home page: ISSN:232-2831 Research article Open Access Formulation and Evaluation
More informationINDUSTRIAL TECHNOLOGY AND PACKAGING (ITP)
Industrial Technology and Packaging (ITP) 1 INDUSTRIAL TECHNOLOGY AND PACKAGING (ITP) ITP Courses ITP 137. Electrical/Electronic Systems. 4 units Electrical and electronic circuit fundamentals. Essential
More informationBiopharmaceutics Applications in Drug Development
Biopharmaceutics Applications in Drug Development Edited by Rajesh Krishna Merck & Co., Inc. Rahwav, NJ. USA and Lawrence Yu Center for Drug Evaluation & Research Rockville, MD, USA 4y Springer Contents
More informationIntroduction to CMC Regulatory Affairs
Introduction to CMC Regulatory Affairs Bharathi Mamidipudi Regulatory Affairs Consultant II Syner-G Pharma Consulting, LLC Northeastern University, Boston November 10, 2016 My Background Experience ~4
More informationRapid Extraction of Therapeutic Oligonucleotides from Primary Tissues for LC/ MS Analysis Using Clarity OTX, an Oligonucleotide Extraction Cartridge
Rapid Extraction of Therapeutic Oligonucleotides from Primary Tissues for LC/ MS Analysis Using Clarity OTX, an Oligonucleotide Extraction Cartridge G. Scott*, H. Gaus #, B. Rivera*, and M. McGinley* *Phenomenex,
More informationMASTER FILE PROCEDURES
MASTER FILE PROCEDURES Natural Health Products Directorate August 2006 Version 1.0 Our mission is to help the people of Canada maintain and improve their health, while respecting individual choices and
More informationKEYWORDS: Pharmaceutical Engineering, Chemical Engineering, Pharmaceutical Industry, Master Degree, Graduate Studies.
International Conference on Engineering Education and Research Progress Through Partnership 2004 VŠB-TUO, Ostrava, ISSN 1562-3580 Core Courses and Core Activities in the Pharmaceutical Engineering Program
More information1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country
1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country S no 1. Name of Applicant with address 2. Name of Drug 3. Therapeutic Class 4. Date of Approval Documents
More informationM. Pharm. (Pharmaceutical Management and Administration)
M. Pharm. (Pharmaceutical Management and Administration) Second Semester Note: Each question Paper will contain seven questions and the candidates are required to attempt any Paper (MPH 201): Management
More informationConventional versus Physiologically-Based (PB)-IVIVC: Revisiting Some Successful and Failed Conventional IVIVC Cases with PB-IVIVC
Conventional versus Physiologically-Based (PB)-IVIVC: Revisiting Some Successful and Failed Conventional IVIVC Cases with PB-IVIVC Nikunj Patel, Senior Research Scientist Simcyp (a Certara Company) AAPS
More informationPHARMACEUTICAL TESTING
WHITEHOUSE, NJ PHARMACEUTICAL TESTING Pharmaceutical Expertise for GMP & CMC Testing Our Pharmaceutical Expertise With more than 20 years of experience in a variety of industries, our Whitehouse, New Jersey
More informationINTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES.
1 INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES www.lsmuni.lt 2 3 About Lithuanian University of Health Sciences Lithuanian University
More informationFormulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza
Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza HorizonChem 2018, March, 6th 2018 1 Content Rottapharm Biotech : Company Overview Formulation
More informationPHARMACOLOGY. Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel ,
PHARMACOLOGY COURSE COORDINATOR: Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel 896 2146, spiersj@tcd.ie ECTS Value 10 Credits Contact Hours 46 hrs lectures 2 tutorials 3 hr 2 computer sessions
More informationPost-Baccalaureate Program in Pharmaceutical Science. Accelerate your career
Post-Baccalaureate Program in Pharmaceutical Science Accelerate your career pharmsci.uci.edu pharmsci-grad@uci.edu 949.824.1991 Improve your career options The Post-Baccalaureate Program in Pharmaceutical
More informationBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies Standard Approach Part I: Design and Conduct H. Rettig, Ph.D. LLC www.ivivc.com Note for Guidance on the Investigation of Bioavailability and Bioequivalence CPMP/EWP/QWP/1401/98
More informationPharmacokinetic & Pharmacodynamic Data Analysis
Pharmacokinetic & Pharmacodynamic Data Analysis CONCEPTS AND APPLICATIONS 4TH EDITION REVISED AND EXPANDED Table of Contents 1. 1.1 1.2 1.3 1.4 1.5 2. 2.1 2.2 2.2.1 2.2.2 2.2.3 2.2.4 2.2.5 2.2.6 2.2.7
More information201 Business Statistics & Research Methodology
MBA (CC) Part-I (Semester-II) 1 201 Business Statistics & Research Methodology The objective of this course is to have a general understanding of Research Methodology and Statistics as applicable to Business
More informationAnalysis of an Acrylic Copolymer using Pyrolysis-GC/MS
FIELD APPLICATION REPORT GAS CHROMATOGRAPHY Analysis of an Acrylic Copolymer using Pyrolysis-GC/MS Author: Thomas Wampler CDS Analytical, Inc. 465 Limestone Road Oxford, PA 19363-0277 Introduction Analytical
More informationPharmaceutical LC/MS Solutions from Agilent Technologies
Pharmaceutical LC/MS Solutions from Agilent Technologies Application Compendium Overview LC/MS plays a key role in the drug discovery and drug development process. Since the introduction of electrospray
More informationPharmaceutical Sciences/Medicinal Chemistry, Ph.D.
Pharmaceutical Sciences/Medicinal Chemistry, Ph.D. 1 Pharmaceutical Sciences/Medicinal Chemistry, Ph.D. SCHOOL OF PHARMACY (http://www.temple.edu/pharmacy) About the Program The School of Pharmacy offers
More informationSize Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column
Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Application Note Bio-Pharmaceutical Authors M. Sundaram Palaniswamy and Andrew Coffey Agilent Technologies,
More informationSUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE
SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE Available online at www.ijdra.com REVIEW ARTICLE 1 Ashara Kalpesh C*, 2 Mendapara Vishal P, 2,3 Mori Nitin M, 4 Badjatya
More informationCURRICULUM MASTER OF BUSINESS ADMINISTRATION IN E-GOVERNANCE
GENERAL SIR JOHN KOTELAWALA DEFENCE UNIVERSITY (MEMBER OF THE ASSOCIATION OF COMMONWEALTHUNIVERSITIESAND INTERNATIONAL ASSOCIATION OF UNIVERSITIES) CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN E-GOVERNANCE
More informationCurrent Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues
Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues Dr. René Thürmer BfArM - and dmedical ldevices AGAH Workshop on Liposomal Formulations Bonn / 21.
More informationCURRICULUM MASTER OF BUSINESS ADMINISTRATION IN LOGISTICS MANAGEMENT
GENERAL SIR JOHN KOTELAWALA DEFENCE UNIVERSITY (MEMBER OF THE ASSOCIATION OF COMMONWEALTHUNIVERSITIESAND INTERNATIONAL ASSOCIATION OF UNIVERSITIES) CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN LOGISTICS
More informationRecent FDA Guidance For Industry; BCS Class 1 and 3 August 2015
Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015 Bryan Crist Scientific Affairs Manager, Agilent Technologies, Dissolution Systems Dissolution Exchange WebEx Bryan.crist@agilent.com August,
More informationRevision of 30 April 2013 draft, 4 November 2013
GUIDANCE DOCUMENT FOR SINGLE LABORATORY VALIDATION OF QUANTITATIVE ANALYTICAL METHODS USED IN SUPPORT OF PRE- AND POST-REGISTRATION DATA REQUIREMENTS FOR PLANT PROTECTION AND BIOCIDAL PRODUCTS INTRODUCTION
More informationBest Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.
Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Specifications Breakout Session 2 Pete Yehl and Mike Coutant, moderators
More informationEVALUATION FOR STABILITY DATA
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION FOR STABILITY DATA Q1E Recommended for
More informationExperimental design on product development
Experimental design on product development Introduction What is the traditional developing method? What is experimental design? What do we need and what kind of possibilities do we have for designing?
More informationPerformance Testing of Novel Dosage Forms
RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies
More informationSeparate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 126 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 3Å, 2.7 µm Column Application Note Biologics
More informationDECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE
DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE Determine impurity level in relevant batches 1 Determine mean + upper confidence limit for the impurity
More informationAgilent solutions for contract research and manufacturing organizations
Agilent solutions for contract research and manufacturing organizations Cooperation between pharmaceutical companies and contract research organizations A successful approach to increasing efficiency along
More informationIdentification of Drug Metabolites via Mass Spectrometry
Identification of Drug Metabolites via Mass Spectrometry Besnik Bajrami Chem 395 Outline Introduction What are Drug Metabolites What is Mass Spec Identification of Drug Metabolites Example Conclusion &
More informationDevelopment of paediatric formulations - points to consider
Development of paediatric formulations - points to consider Workshop on Paediatric Formulations II London, 8 November 2011 Presented by: Ann Marie Kaukonen Scientific Administrator, Paediatric Medicines,
More informationStudy (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética
COURSE DATA Data Subject Code 34081 Name Biopharmacy and Pharmacokinetics Cycle Grade ECTS Credits 10.5 Academic year 2014-2015 Study (s) Degree Center Acad. Period year 1201 - Grado de Farmacia FACULTY
More informationResearch Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form
International Journal of Pharmaceutical Sciences and Nanotechnology 572 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July - September 2009 Volume 2 Issue 2 July
More information3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally
3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry Global Expertise delivered locally Global expertise delivered locally As a global leader in measuring,
More informationSchool of Pharmacy TEMPLE UNIVERSITY
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
More informationADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY BACHELOR OF SCIENCE (Honours) SEMESTER - I
NEW CHOICE BASED CREDIT SYSTEM (TOTAL CREDIT = 22+22+28+28+26+26 = 152) Type of the Paper Paper Code ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY SEMESTER - I / Brief Contents I BT1201
More informationGuideline for the Quality, Safety, and Efficacy Assurance of Follow-on Biologics
Provisional Translation (as of April 19, 2013) PFSB/ELD Notification No. 0304007 March 4, 2009 To: Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food
More informationFORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC
FORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC A Case Study Wendy Saffell-Clemmer Director, R&D Baxter BioPharma Solutions Antibody Drug Conjugates (ADCs) are complex molecules consisting of
More informationMicrobiology, Molecular Biology and Biochemistry
Microbiology, Molecular Biology and Biochemistry Bruce L. Miller, Interim Dept. Head, Dept. of Microbiology, Molecular Biology and Biochemistry (142 Life Sc. Bldg. 83844-3052; phone 208/885-7966; mmbb@uidaho.edu;
More informationApproval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.
Approval Review of Generic Drugs Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Outline of Presentation Introduction Approval Review of Generic Drugs Equivalency review Conformity audit Conclusion
More informationEurofins ADME BIOANALYSES Your partner in drug development
Eurofins ADME BIOANALYSES Your partner in drug development Since 1987, you have placed your confidence in us. Our responsibility, to which my staff and I commit, is to consistently provide you with relevant
More informationFe doped Magnetic Nanodiamonds made by Ion
Fe doped Magnetic Nanodiamonds made by Ion Implantation ChienHsu Chen a, I.C. Cho b, Hui-Shan Jian c and H. Niu a* a Nuclear Science and Technology Development Center, National Tsing Hua University, HsinChu
More informationContent Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )
Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Area 1.0 Basic Biomedical Sciences (10%) Area 2.0 Pharmaceutical Sciences (33%) Area 3.0 Social/Behavioral/Administrative Sciences (22%)
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More informationOctober 26-27, 2017 in Mumbai, India
ELECTROLAB, in collaboration with Simulations Plus, presents: The 2-Day GastroPlus Pharmaceutical Development Workshop October 26-27, 2017 in Mumbai, India Electrolab, in collabration with Simulations
More informationTypes of chromatography
Chromatography Physical separation method based on the differential migration of analytes in a mobile phase as they move along a stationary phase. Mechanisms of Separation: Partitioning Adsorption Exclusion
More informationNeed and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry
43 Review Article Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry Paras Virani 1,2 *, Parul Jain 3, Hasumati
More informationDRUG REGISTRATION REGULATION
DRUG REGISTRATION REGULATION Registration Categories and Application Information Items Requirements of Biological Products Part I I Therapeutic Biological Products Registration Categories 1) Biological
More informationICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
European Medicines Agency August 2003 CPMP/ICH/4680/02 ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
More informationDEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
Department of Biochemistry and Molecular Biology 1 DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Office in Molecular and Radiological Biosciences Building, Room 111 (970) 491-5602 bmb.colostate.edu
More informationTony Mire-Sluis Vice President, Corporate, Product and Device Quality Amgen Inc
The Regulatory Implications of the ever increasing power of Mass Spectrometry and its role in the Analysis of Biotechnology Products Where do we draw the line? Tony Mire-Sluis Vice President, Corporate,
More informationPre-Screening revised checklist for BA/BE NOC for Export Purpose
Pre-Screening revised checklist for BA/BE NOC for Export Purpose O/o Drugs Controller General (India) Directorate General of Health Services FDA Bhawan, New Delhi (With effective from 25 th April 2014)
More informationMETHCATHINONE Latest Revision: July 11, 2005
METHCATHINONE Latest Revision: July 11, 2005 O CH 3 HN CH 3 1. SYNONYMS CFR: Methcathinone CAS #: Base: 5650-44-2 Hydrochloride: 49656-78-2 Other Names: N-methylcathinone Methylcathinone 2-Methylamino-1-phenyl-1-propanone
More informationStructure and content of an IMPD. What is required for first into man trial?
What is required for first into man? The EU IMPD Thomas Sudhop, MD Scope Structure and content of an IMPD What is required for first into man trial? Only for IMPs that do not have a marketing authorisation
More informationfnyyh fo ofo ky; UNIVERSITY OF DELHI SEMESTER EXAMINATIONS - (MAY-2018)
TENTATIVE fnyyh fo ofo ky; UNIVERSITY OF DELHI SEMESTER EXAMINATIONS - (MAY-2018) Date-Sheet for B.Sc. (Programme) Choice Based Credit System Exam (CBCS) Semester Scheme (Admissions of 2015, 2016 & 2017)
More informationPolymer Degradation Mechanisms using Pyrolysis- GC/MS
FIELD APPLICATION REPORT GAS CHROMATOGRAPH Y Polymer Degradation Mechanisms using Pyrolysis- GC/MS Author: Thomas Wampler CDS Analytical, Inc. 465 Limestone Road Oxford, PA 19363-0277 Introduction The
More information